NDC product
Prednisolone Sodium Phosphate
NDC 13925-166 · Seton Pharmaceuticals, LLC
Key facts
| Product NDC | 13925-166 |
|---|---|
| Proprietary name | Prednisolone Sodium Phosphate |
| Nonproprietary name | Prednisolone Sodium Phosphate |
| Substances | PREDNISOLONE SODIUM PHOSPHATE |
| Dosage form | SOLUTION |
| Route | ORAL |
| Labeler | Seton Pharmaceuticals, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA019157 |
| Pharmacologic classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| Marketing start | Oct 18, 2013 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: